Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Lukas Pinkert
  • Yi Hui Lai
  • Carsten Peukert
  • Sven Kevin Hotop
  • Bianka Karge
  • Lara Marie Schulze
  • Jörg Grunenberg
  • Mark Brönstrup

External Research Organisations

  • Helmholtz Centre for Infection Research (HZI)
  • Technische Universität Braunschweig
  • German Center for Infection Research (DZIF)
View graph of relations

Details

Original languageEnglish
Pages (from-to)15440–15460
Number of pages21
JournalJournal of medicinal chemistry
Volume64
Issue number20
Early online date8 Oct 2021
Publication statusPublished - 28 Oct 2021

Abstract

The development of novel drugs against Gram-negative bacteria represents an urgent medical need. To overcome their outer cell membrane, we synthesized conjugates of antibiotics and artificial siderophores based on the MECAM core, which are imported by bacterial iron uptake systems. Structures, spin states, and iron binding properties were predicted in silico using density functional theory. The capability of MECAM to function as an effective artificial siderophore in Escherichia coli was proven in microbiological growth recovery and bioanalytical assays. Following a linker optimization focused on transport efficiency, five β-lactam and one daptomycin conjugates were prepared. The most potent conjugate 27 showed growth inhibition of Gram-positive and Gram-negative multidrug-resistant pathogens at nanomolar concentrations. The uptake pathway of MECAMs was deciphered by knockout mutants and highlighted the relevance of FepA, CirA, and Fiu. Resistance against 27 was mediated by a mutation in the gene encoding ExbB, which is involved in siderophore transport.

ASJC Scopus subject areas

Cite this

Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens. / Pinkert, Lukas; Lai, Yi Hui; Peukert, Carsten et al.
In: Journal of medicinal chemistry, Vol. 64, No. 20, 28.10.2021, p. 15440–15460.

Research output: Contribution to journalArticleResearchpeer review

Pinkert, L, Lai, YH, Peukert, C, Hotop, SK, Karge, B, Schulze, LM, Grunenberg, J & Brönstrup, M 2021, 'Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens', Journal of medicinal chemistry, vol. 64, no. 20, pp. 15440–15460. https://doi.org/10.1021/acs.jmedchem.1c01482
Pinkert, L., Lai, Y. H., Peukert, C., Hotop, S. K., Karge, B., Schulze, L. M., Grunenberg, J., & Brönstrup, M. (2021). Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens. Journal of medicinal chemistry, 64(20), 15440–15460. https://doi.org/10.1021/acs.jmedchem.1c01482
Pinkert L, Lai YH, Peukert C, Hotop SK, Karge B, Schulze LM et al. Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens. Journal of medicinal chemistry. 2021 Oct 28;64(20):15440–15460. Epub 2021 Oct 8. doi: 10.1021/acs.jmedchem.1c01482
Download
@article{de9d96122d7e46a2aebade055c677cc5,
title = "Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens",
abstract = "The development of novel drugs against Gram-negative bacteria represents an urgent medical need. To overcome their outer cell membrane, we synthesized conjugates of antibiotics and artificial siderophores based on the MECAM core, which are imported by bacterial iron uptake systems. Structures, spin states, and iron binding properties were predicted in silico using density functional theory. The capability of MECAM to function as an effective artificial siderophore in Escherichia coli was proven in microbiological growth recovery and bioanalytical assays. Following a linker optimization focused on transport efficiency, five β-lactam and one daptomycin conjugates were prepared. The most potent conjugate 27 showed growth inhibition of Gram-positive and Gram-negative multidrug-resistant pathogens at nanomolar concentrations. The uptake pathway of MECAMs was deciphered by knockout mutants and highlighted the relevance of FepA, CirA, and Fiu. Resistance against 27 was mediated by a mutation in the gene encoding ExbB, which is involved in siderophore transport. ",
author = "Lukas Pinkert and Lai, {Yi Hui} and Carsten Peukert and Hotop, {Sven Kevin} and Bianka Karge and Schulze, {Lara Marie} and J{\"o}rg Grunenberg and Mark Br{\"o}nstrup",
note = "Funding Information: This project was funded by the DFG (grant number: BR 3572/4-1) and the Joint Program Initiative on Antimicrobial Resistance (JPI AMR, grant number: 01KI1825). C.P. thanks the “Fonds der chemischen Industrie” for a scholarship. ",
year = "2021",
month = oct,
day = "28",
doi = "10.1021/acs.jmedchem.1c01482",
language = "English",
volume = "64",
pages = "15440–15460",
journal = "Journal of medicinal chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "20",

}

Download

TY - JOUR

T1 - Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens

AU - Pinkert, Lukas

AU - Lai, Yi Hui

AU - Peukert, Carsten

AU - Hotop, Sven Kevin

AU - Karge, Bianka

AU - Schulze, Lara Marie

AU - Grunenberg, Jörg

AU - Brönstrup, Mark

N1 - Funding Information: This project was funded by the DFG (grant number: BR 3572/4-1) and the Joint Program Initiative on Antimicrobial Resistance (JPI AMR, grant number: 01KI1825). C.P. thanks the “Fonds der chemischen Industrie” for a scholarship.

PY - 2021/10/28

Y1 - 2021/10/28

N2 - The development of novel drugs against Gram-negative bacteria represents an urgent medical need. To overcome their outer cell membrane, we synthesized conjugates of antibiotics and artificial siderophores based on the MECAM core, which are imported by bacterial iron uptake systems. Structures, spin states, and iron binding properties were predicted in silico using density functional theory. The capability of MECAM to function as an effective artificial siderophore in Escherichia coli was proven in microbiological growth recovery and bioanalytical assays. Following a linker optimization focused on transport efficiency, five β-lactam and one daptomycin conjugates were prepared. The most potent conjugate 27 showed growth inhibition of Gram-positive and Gram-negative multidrug-resistant pathogens at nanomolar concentrations. The uptake pathway of MECAMs was deciphered by knockout mutants and highlighted the relevance of FepA, CirA, and Fiu. Resistance against 27 was mediated by a mutation in the gene encoding ExbB, which is involved in siderophore transport.

AB - The development of novel drugs against Gram-negative bacteria represents an urgent medical need. To overcome their outer cell membrane, we synthesized conjugates of antibiotics and artificial siderophores based on the MECAM core, which are imported by bacterial iron uptake systems. Structures, spin states, and iron binding properties were predicted in silico using density functional theory. The capability of MECAM to function as an effective artificial siderophore in Escherichia coli was proven in microbiological growth recovery and bioanalytical assays. Following a linker optimization focused on transport efficiency, five β-lactam and one daptomycin conjugates were prepared. The most potent conjugate 27 showed growth inhibition of Gram-positive and Gram-negative multidrug-resistant pathogens at nanomolar concentrations. The uptake pathway of MECAMs was deciphered by knockout mutants and highlighted the relevance of FepA, CirA, and Fiu. Resistance against 27 was mediated by a mutation in the gene encoding ExbB, which is involved in siderophore transport.

UR - http://www.scopus.com/inward/record.url?scp=85117450279&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.1c01482

DO - 10.1021/acs.jmedchem.1c01482

M3 - Article

AN - SCOPUS:85117450279

VL - 64

SP - 15440

EP - 15460

JO - Journal of medicinal chemistry

JF - Journal of medicinal chemistry

SN - 0022-2623

IS - 20

ER -